Biofidelity

Biofidelity is a Cambridge-based genomic technology company developing molecular assays for cancer biomarker detection in tissue and liquid biopsy samples.

Its proprietary platform enables ultra-sensitive detection of somatic mutations at low variant allele fractions using a simplified four-step qPCR workflow, without requiring next-generation sequencing infrastructure. Products are designed for adoption in existing diagnostic laboratories globally.

Current applications focus on non-small cell lung cancer biomarker profiling to guide targeted therapy selection and treatment monitoring.